http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#Head
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#assertion
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#provenance
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#pubinfo
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#assertion
http://purl.obolibrary.org/obo/DOID_13268
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_13268
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB01174
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#association
http://www.w3.org/2000/01/rdf-schema#label
"Barbiturates are contraindicated in patients with known barbiturate sensitivity. Barbiturates are also contraindicated in patients with a history of manifest or latent porphyria, marked impairment of liver functions or with severe respiratory distress where dyspnea or obstruction is evident. Large doses are contraindicated in nephritic subjects. Barbiturates should not be administered to persons with known previous addiction to the sedative-hypnotic group since ordinary doses may be ineffectual and may contribute to further addiction. Intraarterial administration is contraindicated. Its consequences vary from transient pain to gangrene. Subcutaneous administration produces tissue irritation, ranging from tenderness and redness to necrosis and is not recommended. (See DOSAGE AND ADMINISTRATION, Treatment of Adverse Effects Due to Inadvertent Error in Administration"
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#association
https://w3id.org/biolink/vocab/relation
https://schema.org/MedicalContraindication
https://identifiers.org/drugbank:DB01174
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#provenance
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#pubinfo
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#sig
http://purl.org/nanopub/x/hasSignature
IQg/HJ/OWImLc07tN/VnRHA3oF4CnZNSPYY5VCCSoDriJA0guK1AcndMrVIPUWsjG3QTS+gUbK1a0huPXBDz2Ei+Zj6rLW31tdyOg2kC7mpPQv2EqXjV/7LcvZilbkVTayp6psE/IKGLRJ8wd7Ggaz0wDOcvfjz+FTnMOYLwu1c=
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg
http://purl.org/dc/terms/created
2021-08-23T18:04:31.262+02:00
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RA-a4uzT_fwKCpYOhDjHLlzHq7zJ8d1qD6KDDTryJDgYg
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY